LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Innovation policy and the market for vaccines.

    Xue, Qiwei Claire / Ouellette, Lisa Larrimore

    Journal of law and the biosciences

    2020  Volume 7, Issue 1, Page(s) lsaa026

    Abstract: Vaccines play a crucial role in improving global public health, with the ability to stem the spread of infectious diseases and the potential to eradicate them completely. Compared with pharmaceuticals that treat disease, however, preventative vaccines ... ...

    Abstract Vaccines play a crucial role in improving global public health, with the ability to stem the spread of infectious diseases and the potential to eradicate them completely. Compared with pharmaceuticals that treat disease, however, preventative vaccines have received less attention from both biomedical researchers and innovation scholars. This neglect has substantial human and financial costs, as vividly illustrated by the COVID-19 pandemic. In this article, we argue that the large number of ``missing'' vaccines is likely due to more than lack of scientific opportunities. Two key aspects of vaccines help account for their anemic development pipeline: (1) they are preventatives rather than treatments; and (2) they are generally durable goods with long-term effects rather than products purchased repeatedly. We explain how both aspects make vaccines less profitable than repeat-purchase treatments, even given comparable IP protection. We conclude by arguing that innovation policy should address these market distortions by experimenting with larger government-set rewards for vaccine production and use. Most modestly, policymakers should increase direct funding-including no grants and public-private partnerships-and insurance-based market subsidies for vaccine development. We also make the case for a large cash prize for any new vaccine made available at low or zero cost.
    Keywords covid19
    Language English
    Publishing date 2020-05-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2756090-9
    ISSN 2053-9711
    ISSN 2053-9711
    DOI 10.1093/jlb/lsaa026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Innovation policy and the market for vaccines

    Xue, Qiwei Claire / Ouellette, Lisa Larrimore

    Journal of law and the biosciences

    Abstract: Vaccines play a crucial role in improving global public health, with the ability to stem the spread of infectious diseases and the potential to eradicate them completely Compared with pharmaceuticals that treat disease, however, preventative vaccines ... ...

    Abstract Vaccines play a crucial role in improving global public health, with the ability to stem the spread of infectious diseases and the potential to eradicate them completely Compared with pharmaceuticals that treat disease, however, preventative vaccines have received less attention from both biomedical researchers and innovation scholars This neglect has substantial human and financial costs, as vividly illustrated by the COVID-19 pandemic In this article, we argue that the large number of ``missing'' vaccines is likely due to more than lack of scientific opportunities Two key aspects of vaccines help account for their anemic development pipeline: (1) they are preventatives rather than treatments;and (2) they are generally durable goods with long-term effects rather than products purchased repeatedly We explain how both aspects make vaccines less profitable than repeat-purchase treatments, even given comparable IP protection We conclude by arguing that innovation policy should address these market distortions by experimenting with larger government-set rewards for vaccine production and use Most modestly, policymakers should increase direct funding-including no grants and public-private partnerships-and insurance-based market subsidies for vaccine development We also make the case for a large cash prize for any new vaccine made available at low or zero cost
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #691293
    Database COVID19

    Kategorien

  3. Article ; Online: Innovation policy and the market for vaccines*

    Xue, Qiwei Claire / Ouellette, Lisa Larrimore

    Journal of Law and the Biosciences

    2020  Volume 7, Issue 1

    Abstract: Abstract Vaccines play a crucial role in improving global public health, with the ability to stem the spread of infectious diseases and the potential to eradicate them completely. Compared with pharmaceuticals that treat disease, however, preventative ... ...

    Abstract Abstract Vaccines play a crucial role in improving global public health, with the ability to stem the spread of infectious diseases and the potential to eradicate them completely. Compared with pharmaceuticals that treat disease, however, preventative vaccines have received less attention from both biomedical researchers and innovation scholars. This neglect has substantial human and financial costs, as vividly illustrated by the COVID-19 pandemic. In this article, we argue that the large number of ``missing'' vaccines is likely due to more than lack of scientific opportunities. Two key aspects of vaccines help account for their anemic development pipeline: (1) they are preventatives rather than treatments; and (2) they are generally durable goods with long-term effects rather than products purchased repeatedly. We explain how both aspects make vaccines less profitable than repeat-purchase treatments, even given comparable IP protection. We conclude by arguing that innovation policy should address these market distortions by experimenting with larger government-set rewards for vaccine production and use. Most modestly, policymakers should increase direct funding—including no grants and public-private partnerships—and insurance-based market subsidies for vaccine development. We also make the case for a large cash prize for any new vaccine made available at low or zero cost.
    Keywords covid19
    Language English
    Publisher Oxford University Press (OUP)
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 2756090-9
    ISSN 2053-9711
    ISSN 2053-9711
    DOI 10.1093/jlb/lsaa026
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top